CannTrust Holdings Inc. (NYSE: CTST) shares have taken another big hit after the company announced late Thursday that it's going to hold off all of its cannabis products sales and shipments until Health Canada examines its Vaughan Ontario manufacturing facility.
The problem arose earlier this week when Canadian authorities discovered CannTrust’s greenhouse facility in Pelham, Ontario doesn’t comply with all Canadian health regulations. Five unlicensed rooms were found at the facility, after which the authorities had placed a hold on 5,200 kg of dried cannabis produced there.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!
The company also announced a formation of a Special Committee of the Board of Directors for the purpose of a thorough investigation of the situation.
The effects on the company’s financial performance are still unclear, and it will remain that way until the investigation is completed.
In the aftermath, the company’s shares fell 10.61% to $2.78 in Friday’s pre-market session.
Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.
'420 Investor' Brochstein To CannTrust CEO: Apologize And Resign
Bank Of America Double Downgrades CannTrust After Health Canada Findings
See more from Benzinga
- Supreme Cannabis Closes Acquisition Of Blissco Cannabis
- Avicanna Gets Conditional Approval To List On Toronto Stock Exchange Senior Board As R&D Issuer
- United Cannabis Corp Names Clifton Lamberth As Chief Marketing Officer
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.